SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: DR.TECH who wrote (7397)4/24/1998 5:02:00 AM
From: DAY TRADER  Read Replies (1) | Respond to of 23519
 
MUSE is more expensive and of course more

painful and inconvenient to use than Viagra.

MUSE has been on the market for a while

hasn't caused any wave of earnings.

Vivus has only two products, one of which

is probably not worth mentioning.

One could speculate and buy the stock on pure momentum,

but once momentum leaves watch out below!

These sympathy plays are very dangerous!

Look TRAC

DT



To: DR.TECH who wrote (7397)4/24/1998 7:04:00 AM
From: blankmind  Read Replies (2) | Respond to of 23519
 
Dr. Tech - once again you've hit on an old but true theme - that VVUS's sales are going to increase.

- Who cares if VVUS drops to #2? As long as they can do $2+ a share in '99?

- Also, the shorts are toast. Does anyone know when VVUS new short position will come out?

- And there's no chance of a short squeeze today. I checked with my broker yesterday, and they had shares available for shorting.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News